UnitedHealth Group's Stock Surge Driven by Deliberate Management Decisions

UnitedHealth Group's stock has risen significantly over the past year, outperforming its peers in the managed care sector. However, a closer look at the company's financials reveals that this growth was not solely due to an increase in volume, but rather a result of deliberate actions taken by management.

In July 2025, before the stock surge began, UnitedHealth announced plans to exit Medicare Advantage plans serving over 600,000 members, primarily in less-managed products such as PPO offerings. The company also shifted towards narrower networks in Medicare Advantage, which would lead to a smaller Medicare book by 2026.

The management team had set a target of expanding Medicare margins to a range of 2.5% to 3% by 2026, with the repricing date for about 80% of premium revenue set for January 1. This would allow the company to reap the benefits of pricing actions and margin expansion in one step.

As of its fiscal Q1 2025 results, UnitedHealth's trailing-twelve-month revenue grew by 8.1%, compared to an average growth rate of 11.3% over the previous three years. The company's operating earnings rose by 55% year-over-year in the second quarter of 2026, with a significant portion coming from net favorable prior period development.

UnitedHealth has since revised its full-year 2026 outlook, expecting Medicare margins to exceed 3%, and full-year Medicare Advantage enrollment to decline by approximately 1.1 million members. The company's ability to increase profitability through pricing actions and plan exits rather than volume growth is a key takeaway from this story.